Download Files:
Products Details
Product Description
– β-Lactamase-IN-4 is a β-lactamase inhibitor extracted from patent WO2013149121A1, compound 708. β-Lactamase-IN-4 can be used for the research of bacterial infections[1].
Web ID
– HY-139751
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C11H15N5O6S
References
– [1]Gu YG, et, al. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors. WO2013149121A1.
CAS Number
– 1463520-91-3
Molecular Weight
– 345.33
SMILES
– O=C1[N@]2[C@@](C3=NN=C(C4CNC4)O3)([H])CC[C@@H](N1OS(=O)(O)=O)C2
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Bacterial
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
